• Citron OGD2 Links Iron, ROS, and Canker Resistance

  2026-09-26

  The study identifies Citron CmOGD2 as a contributor to resistance against citrus canker, linking iron uptake and reactive oxygen species to a likely ferroptosis-like defense response. It also reveals feedback regulation by CmENO2 and CmZAT10.1, and shows how the Xanthomonas effector pthA4 may disrupt that feedback to favor infection.

• Z-DEVD-FMK: Mapping Caspase Signaling in Tumors

  2026-09-25

  Z-DEVD-FMK is a cell-permeable caspase-3 inhibitor that can help dissect apoptotic signaling—but its broader target profile matters. This article connects inhibitor design to DR5-driven PD-L1 stabilization and shows how to interpret experiments without mistaking pathway perturbation for target specificity.

• CHIR-99021 in Intestinal Organoid Workflows

  2026-09-25

  Use CHIR-99021 as a timed, testable GSK-3 switch—not as a substitute for a defined intestinal differentiation protocol. Pair pathway readouts with controlled culture environments to separate signaling effects from matrix-driven changes in human intestinal organoids.

• Merbromin Inhibits SARS-CoV-2 3CLpro by Mixed-Type Binding

  2026-09-24

  A biochemical screen of approximately 6,000 compounds identified merbromin as an inhibitor of SARS-CoV-2 3CLpro, with enzyme kinetics indicating mixed-type inhibition. Selectivity tests, binding assays, and molecular docking support merbromin as a useful lead for further study, while leaving its antiviral efficacy and therapeutic potential unresolved.

• EdU Flow Cytometry Assay Kits (Cy5) in Wound Biology

  2026-09-24

  Pair S-phase DNA-synthesis measurement with mechanistic studies of epithelial repair to distinguish cell-cycle effects from changes in migration or survival. The Cy5 click-chemistry workflow avoids harsh DNA denaturation and can be integrated with cell-cycle dyes or selected antibody panels.

• Concanamycin A: Read Trafficking Before Cell Death

  2026-09-23

  Concanamycin A is a potent V-type H+-ATPase inhibitor, but its effects reach beyond a single cell-death pathway. This article shows how to use trafficking and acidification readouts to interpret cancer-cell responses without mistaking a downstream phenotype for target engagement.

• Novobiocin Sodium: Applied Research Workflows

  2026-09-23

  Novobiocin Sodium connects bacterial DNA gyrase inhibition with practical workflows for replication stress, cell viability, and exploratory antiparasitic assays. This guide emphasizes fresh-solution handling, quantitative controls, cross-domain interpretation, and troubleshooting for DNA damage, apoptosis, and antibiotic resistance research.

• LAMP1 Controls CXCL10-CXCR3 Macrophage Polarization

  2026-09-22

  A 2024 International Immunopharmacology study identifies LAMP1-linked autophagy as a context-dependent regulator of CXCL10-CXCR3 signaling in macrophages. Its findings show that CXCR3 antagonism can produce opposite polarization outcomes in non-inflammatory and poly(I:C)-stimulated cells, while also reducing experimental acute lung injury.

• Streptavidin-Cy3 for Spatial Mechanism Assays

  2026-09-22

  Streptavidin-Cy3 can connect biotinylated antibodies and nucleic acid probes to spatially resolved evidence. This guide translates the seRNA-NPCm/NPM1/c-Myc/NDRG1 findings into practical assay-selection, control, and interpretation strategies.

• Candida EVs, Nrg1, and Hyphal Suppression

  2026-09-21

  This study identifies a concentration- and time-dependent feedback mechanism in which Candida albicans extracellular vesicles increase NRG1 expression and suppress hyphal development through an SKO1-associated regulatory axis. Genetic, transcriptomic, and mouse candidemia experiments indicate that EV cargo proteins can reduce fungal virulence, although the physiological relevance and molecular identity of the active cargo remain to be established.

• Beyond Hits: Translating Immune Phenotypes

  2026-09-21

  A mechanism-first framework for using multiparametric PBMC phenotyping and curated small-molecule collections to connect immune-cell responses with actionable inflammation biology.

• Proteinase K: Assay Design Beyond DNA Prep

  2026-09-20

  Proteinase K is more than a genomic DNA isolation enzyme: it is a useful proteolysis control for interpreting inhibitor assays. This article connects its biochemical selectivity and operating range with the SARS-CoV-2 3CLpro screening strategy reported for merbromin.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit

  2026-09-19

  Learn how SKU K1062 supports reproducible fluorescent RNA probe synthesis for in situ hybridization and Northern blot workflows linked to cell viability, proliferation, and cytotoxicity studies. This scenario-based guide covers probe design, Cy5-UTP optimization, interpretation, and practical product selection.

• ZNF263–ULK1 Autophagy Axis in Cholangiocarcinoma

  2026-09-18

  The reference study identifies ZNF263 as an oncogenic transcription factor in intrahepatic cholangiocarcinoma and connects its activity to ULK1-dependent autophagy. By integrating tissue analysis, functional assays, CUT&Tag, transcriptomics, enhancer validation, and rescue experiments, the authors propose a mechanistic route linking chromatin regulation with tumor-cell proliferation.

• Pioglitazone Workflows for PPARγ Research

  2026-09-18

  Pioglitazone is a practical PPARγ agonist for connecting metabolic transcriptional control with beta-cell resilience and inflammatory process modulation. This workflow-oriented guide translates macrophage-polarization evidence into cell, barrier, and disease-model assays while emphasizing formulation, controls, and interpretation.

7813 records 1/521 page Next 12345 下5页 Last page